Last, a recent study has shown that by activating the liver X receptor alpha (LXRa) and inhibiting the Raf-1-SCD1 protein complex in liver carcinomas, an intracellular accumulation of saturated free fatty acids occurs and leads to lethal lipotoxicity in these tumor cells. Here, RAF1 is linked to hepatocellular carcinoma.